Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis.
Sudlow
Cathie L M
CL
Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU. csudlow@skull.dcn.ed.ac.uk
Counsell
Carl E
CE
D015982:Bias; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D004341:Drug Evaluation / Q000191:economics; D006076:Government; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000191:economics; D019057:Quality-Adjusted Life Years; D020414:Risk Sharing, Financial; D006113:United Kingdom